Insmed Incorporated (INSM)
NASDAQ
Market Cap
$11.12B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
616 of 809
Rank in Industry
338 of 445
Largest Insider Buys in Sector
INSM Stock Price History Chart
INSM Stock Performance
About Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Insider Activity of Insmed Incorporated
Over the last 12 months, insiders at Insmed Incorporated have bought $0 and sold $36.42M worth of Insmed Incorporated stock.
On average, over the past 5 years, insiders at Insmed Incorporated have bought $961,331 and sold $19.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $385,800 was made by SHAROKY MELVIN MD (director) on 2023‑05‑15.
List of Insider Buy and Sell Transactions, Insmed Incorporated
| 2024-06-10 | Sale | Flammer Martina M.D. | Chief Medical Officer | 21,195 0.0132% | $60.00 | $1.27M | +8.02% | |
| 2024-06-03 | Sale | Schaeffer Orlov S Nicole | Chief People Strategy Officer | 55,000 0.0366% | $55.33 | $3.04M | +10.38% | |
| 2024-05-30 | Sale | Flammer Martina M.D. | Chief Medical Officer | 21,195 0.0138% | $55.00 | $1.17M | +8.20% | |
| 2024-05-29 | Sale | Bonstein Sara | Chief Financial Officer | 220,564 0.1386% | $50.00 | $11.03M | +15.11% | |
| 2024-05-28 | Sale | Bonstein Sara | Chief Financial Officer | 20,724 0.0145% | $50.01 | $1.04M | +28.13% | |
| 2024-05-28 | Sale | Wise John Drayton | Chief Commercial Officer | 7,852 0.0055% | $49.79 | $390,918 | +28.13% | |
| 2024-05-28 | Sale | Schaeffer Orlov S Nicole | Chief People Strategy Officer | 27,500 0.0191% | $49.53 | $1.36M | +28.13% | |
| 2024-05-28 | Sale | Flammer Martina M.D. | Chief Medical Officer | 103,806 0.0721% | $49.62 | $5.15M | +28.13% | |
| 2024-05-28 | Sale | Smith Michael Alexander | Chief Legal Officer | 44,722 0.031% | $49.53 | $2.22M | +28.13% | |
| 2024-05-17 | Sale | Adsett Roger | Chief Operating Officer | 5,945 0.004% | $25.09 | $149,160 | +130.90% | |
| 2024-05-17 | Sale | Flammer Martina M.D. | Chief Medical Officer | 4,642 0.0032% | $25.09 | $116,468 | +130.90% | |
| 2024-05-14 | Sale | Lewis William | Chair and CEO | 22,198 0.015% | $25.52 | $566,493 | +124.06% | |
| 2024-05-14 | Sale | Adsett Roger | Chief Operating Officer | 7,857 0.0053% | $25.50 | $200,354 | +124.06% | |
| 2024-05-14 | Sale | Wise John Drayton | Chief Commercial Officer | 5,088 0.0034% | $25.47 | $129,591 | +124.06% | |
| 2024-05-14 | Sale | Bonstein Sara | Chief Financial Officer | 11,088 0.0074% | $25.32 | $280,748 | +124.06% | |
| 2024-05-14 | Sale | Flammer Martina M.D. | Chief Medical Officer | 10,640 0.0072% | $25.47 | $271,001 | +124.06% | |
| 2024-05-14 | Sale | Schaeffer Orlov S Nicole | Chief People Strategy Officer | 6,508 0.0044% | $25.53 | $166,149 | +124.06% | |
| 2024-05-14 | Sale | Smith Michael Alexander | Chief Legal Officer | 5,093 0.0034% | $25.40 | $129,362 | +124.06% | |
| 2024-01-12 | Sale | Adsett Roger | Chief Operating Officer | 5,251 0.0037% | $28.63 | $150,336 | -2.55% | |
| 2024-01-12 | Sale | Flammer Martina M.D. | Chief Medical Officer | 4,667 0.0033% | $28.63 | $133,616 | -2.55% |
Insider Historical Profitability
17.58%
| Lewis William | Chair and CEO | 384125 0.2542% | $68.98 | 7 | 24 | +45.59% |
| Adsett Roger | Chief Operating Officer | 149275 0.1038% | $68.98 | 1 | 17 | +43.16% |
| Bonstein Sara | Chief Financial Officer | 117481 0.0797% | $68.98 | 0 | 10 | |
| Wise John Drayton | Chief Commercial Officer | 121657 0.0796% | $68.98 | 0 | 12 | |
| Flammer Martina M.D. | Chief Medical Officer | 106134 0.0747% | $68.98 | 0 | 18 | |
| Schaeffer Orlov S Nicole | Chief People Strategy Officer | 108760 0.0713% | $68.98 | 0 | 22 | |
| Smith Michael Alexander | General Counsel, Senior VP | 88828 0.0604% | $68.98 | 0 | 15 | |
| ALLAN GEOFFREY | President, CEO and Chairman | 1166464 0.8154% | $68.98 | 1 | 0 | +1.39% |
| ENGELSEN STEINAR J | director | 320802 0.2242% | $68.98 | 9 | 0 | +12.65% |
| SHAROKY MELVIN MD | director | 298615 0.2087% | $68.98 | 13 | 7 | +30.85% |
| TULLY KEVIN P | Executive VP & CFO | 142252 0.0994% | $68.98 | 1 | 0 | <0.0001% |
| Pellizzari Christine A | Chief Legal Officer | 140721 0.0984% | $68.98 | 4 | 8 | +50.93% |
| LEE LEO | director | 98265 0.0687% | $68.98 | 1 | 0 | +15.36% |
| Brennan David R | director | 80876 0.0565% | $68.98 | 1 | 0 | <0.0001% |
| Glover Steve C | President Follow-on Biologics | 80000 0.0559% | $68.98 | 1 | 0 | <0.0001% |
| Farrar Doug | Vice President, ITP | 74813 0.0523% | $68.98 | 4 | 0 | <0.0001% |
| HAYDEN DONALD J JR | director | 62197 0.0435% | $68.98 | 3 | 8 | <0.0001% |
| CROOKE GRAHAM K | director | 60000 0.0419% | $68.98 | 3 | 0 | <0.0001% |
| SORIANO JOHN | Chief Compliance Officer | 35204 0.0246% | $68.98 | 0 | 5 | |
| WHITCOMB RANDALL W | director | 29840 0.0209% | $68.98 | 2 | 1 | <0.0001% |
| ALTOMARI ALFRED | director | 20938 0.0146% | $68.98 | 0 | 5 | |
| Whitten Timothy | President & CEO | 10000 0.007% | $68.98 | 2 | 0 | +43.09% |
| Drechsler Andrew T | Chief Financial Officer | 5000 0.0035% | $68.98 | 0 | 2 | |
| FMR LLC | 10 percent owner | 2221 0.0016% | $68.98 | 0 | 21 | |
| GUPTA RENU | EVP & Chief Medical Officer | 2000 0.0014% | $68.98 | 2 | 0 | <0.0001% |
| CONDON KENNETH G | director | 100 0.0001% | $68.98 | 0 | 15 | |
| Quigley Mark | Vice President, Quality | 0 0% | $68.98 | 0 | 1 | |
| POTTER MYRTLE S | director | 0 0% | $68.98 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| The Vanguard Group | $393.64M | 9.76 | 14.51M | +2.72% | +$10.41M | 0.01 | |
| BlackRock | $320.13M | 7.94 | 11.8M | +2.67% | +$8.34M | 0.01 | |
| T. Rowe Price | $292.17M | 7.25 | 10.77M | +0.05% | +$151,792.92 | 0.04 | |
| Fidelity Investments | $252.82M | 6.27 | 9.32M | +83.02% | +$114.69M | 0.02 | |
| State Street | $160.21M | 3.97 | 5.91M | -0.42% | -$672,986.78 | 0.01 | |
| Deep Track Capital Lp | $129.78M | 3.22 | 4.78M | -10.59% | -$15.36M | 0.6 | |
| Palo Alto Investors Lp | $120.01M | 2.98 | 4.42M | -19.75% | -$29.53M | 13.53 | |
| William Blair Investment Management | $114.35M | 2.84 | 4.21M | -0.99% | -$1.14M | 0.3 | |
| Macquarie Group | $105.79M | 2.62 | 3.9M | -16.17% | -$20.4M | 0.09 | |
| Franklin Templeton Investments | $96.77M | 2.4 | 3.57M | +5.01% | +$4.62M | 0.03 | |
| T Rowe Price Investment Management Inc | $93.64M | 2.32 | 3.45M | -41.01% | -$65.09M | 0.06 | |
| Geode Capital Management | $85.85M | 2.13 | 3.16M | +3.08% | +$2.56M | 0.01 | |
| Ameriprise Financial | $74.21M | 1.84 | 2.74M | +19.84% | +$12.29M | 0.02 | |
| Janus Henderson | $60.49M | 1.5 | 2.23M | +58.9% | +$22.42M | 0.03 | |
| AllianceBernstein | $58.23M | 1.44 | 2.15M | -0.07% | -$38,605.99 | 0.02 | |
| Bellevue Group | $58.11M | 1.44 | 2.14M | -6.51% | -$4.05M | 0.89 | |
| BNY Mellon | $55.65M | 1.38 | 2.05M | -12.96% | -$8.29M | 0.01 | |
| Suvretta Capital Management, LLC | $54.88M | 1.36 | 2.02M | -24.64% | -$17.95M | 2.32 | |
| RTW Investments, LP | $50.6M | 1.26 | 1.87M | 0% | +$0 | 0.75 | |
| Capital International Investors | $43.97M | 1.09 | 1.62M | New | +$43.97M | 0.01 | |
| Loomis, Sayles & Company | $40.47M | 1 | 1.49M | -36.02% | -$22.78M | 0.06 | |
| First Trust | $38.99M | 0.97 | 1.44M | +1,398.12% | +$36.39M | 0.04 | |
| Novo Holdings A/S | $36.34M | 0.9 | 1.34M | 0% | +$0 | 2.54 | |
| Northern Trust | $36.27M | 0.9 | 1.34M | -2.58% | -$961,704.25 | 0.01 | |
| Marshall Wace | $36.08M | 0.9 | 1.33M | -7.62% | -$2.98M | 0.05 | |
| Integral Health Asset Management Llc | $35.27M | 0.88 | 1.3M | +271.43% | +$25.77M | 3.49 | |
| GW&K Investment Management | $34.45M | 0.86 | 1.27M | -1.69% | -$593,435.89 | 0.3 | |
| Assenagon Asset Management S.A. | $32.87M | 0.82 | 1.21M | +325.83% | +$25.15M | 0.09 | |
| Octagon Capital Advisors LP | $30.93M | 0.77 | 1.14M | -11.21% | -$3.91M | 4.05 | |
| Charles Schwab | $30.57M | 0.76 | 1.13M | -0.15% | -$45,279.97 | 0.01 | |
| Bank of America | $27.02M | 0.67 | 996,128 | -4.57% | -$1.29M | <0.01 | |
| Hood River Capital Management LLC | $26.11M | 0.65 | 962,501 | +6.26% | +$1.54M | 0.58 | |
| Morgan Stanley | $25.49M | 0.63 | 939,603 | -38.78% | -$16.15M | <0.01 | |
| ClearBridge Investments | $25.24M | 0.63 | 930,409 | New | +$25.24M | 0.02 | |
| Citadel Advisors LLC | $25.16M | 0.62 | 927,563 | -11.34% | -$3.22M | 0.02 | |
| Great Point Partners | $21.04M | 0.52 | 775,585 | +243.31% | +$14.91M | 3.53 | |
| Goldman Sachs | $20.45M | 0.51 | 753,610 | -1.07% | -$221,435.07 | <0.01 | |
| Frontier Capital Management Co | $20.28M | 0.5 | 747,331 | New | +$20.28M | 0.19 | |
| Fil Ltd | $19.54M | 0.49 | 720,245 | +4.17% | +$781,723.83 | 0.02 | |
| Two Sigma Advisers LP | $19.44M | 0.48 | 716,400 | +13.86% | +$2.37M | 0.03 | |
| American Century Investments | $19.06M | 0.47 | 702,624 | +6.11% | +$1.1M | 0.01 | |
| Eventide Asset Management | $17.23M | 0.43 | 635,185 | 0% | +$0 | 0.27 | |
| Emerald Advisers, Inc. | $17.1M | 0.42 | 630,179 | -32.3% | -$8.16M | 0.7 | |
| Hudson Bay Capital Management LP | $17.01M | 0.42 | 626,810 | +34.08% | +$4.32M | 0.18 | |
| Samlyn Capital, LLC | $15.94M | 0.4 | 587,634 | -54.34% | -$18.97M | 0.28 | |
| Cormorant Asset Management Lp | $15.6M | 0.39 | 575,000 | 0% | +$0 | 0.74 | |
| Nuveen | $14.58M | 0.36 | 537,231 | +42.42% | +$4.34M | <0.01 | |
| Bioimpact Capital Llc | $14.4M | 0.36 | 530,794 | +0.5% | +$71,731.72 | 2.33 | |
| HERITAGE ASSET MANAGEMENT INC | $14.01M | 0.35 | 524,372 | -4.42% | -$648,253.88 | 0.07 | |
| Panagora | $13.97M | 0.35 | 514,829 | +20.01% | +$2.33M | 0.07 |